论文信息 - LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer - 字舞流文

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

A. Cardona | A. Avilés-Salas | O. Arrieta | L. Lara-Mejía | D. Díaz-García | N. Hernández-Pedro | M. Orozco-Morales | M. Ramos-Ramírez | Dr. Rodrigo Catalan | Eduardo Rios-Garcia